| New Enterprise Associates 15, L.P. |
Non-Executive |
Arcellx, Inc. (ACLX)
|
2022-06-21 |
$16.00 |
339.8% |
312,500
|
$5,000,000 |
| New Enterprise Associates 15, L.P. |
Non-Executive |
Arcellx, Inc. (ACLX)
|
2022-02-08 |
$15.00 |
369.1% |
1,583,333
|
$23,749,995 |
| New Enterprise Associates 15, L.P. |
Non-Executive |
Reneo Pharmaceuticals, Inc. (RPHM)
|
2021-04-13 |
$150.00 |
-99.0% |
66,667
|
$9,999,990 |
| New Enterprise Associates 15, L.P. |
Non-Executive |
Eargo, Inc. (EAR)
|
2020-10-20 |
$360.00 |
-99.3% |
15,556
|
$5,599,998 |
| New Enterprise Associates 15, L.P. |
Non-Executive |
Inozyme Pharma, Inc. (INZY)
|
2020-07-28 |
$16.00 |
-67.4% |
250,000
|
$4,000,000 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
178.9% |
$86,500,102 |
$48,349,983 |